HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC17A3
solute carrier family 17 member 3
Chromosome 6 · 6p22.2
NCBI Gene: 10786Ensembl: ENSG00000124564.18HGNC: HGNC:10931UniProt: O00476
26PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
apical plasma membraneendoplasmic reticulum membraneurate transmembrane transporter activityefflux transmembrane transporter activitytype 1 diabetes mellitusgouthypoxanthine guanine phosphoribosyltransferase partial deficiencyfamilial juvenile hyperuricemic nephropathy type 1
✦AI Summary

SLC17A3 encodes a voltage-driven, multispecific organic anion transporter localized on the apical membrane of renal proximal tubular epithelial cells 1. The primary function is mediating renal secretion of urate, the end product of purine metabolism, from cells into the urinary lumen 1. The transporter also handles diverse substrates including drugs (bumetanide, furosemide), steroid conjugates (estrone sulfate, estradiol-17-beta-glucuronide), toxins (ochratoxin A), and metabolites like N-lactoyl-phenylalanine (Lac-Phe) and 3-indoxyl sulfate 123. SLC17A3 operates through voltage-driven efflux mechanisms, with demonstrated transport kinetics for substrates like 3-indoxyl sulfate (Km = 4.52 mM) 3. Loss-of-function mutations in SLC17A3 cause urate underexcretion, contributing to hyperuricemia and gout susceptibility 4. Clinical significance includes associations with hyperuricemia, gout, and potentially ischemic stroke risk in certain populations 5. Genetic variants account for significant portions of serum urate variance and may influence type 1 diabetes susceptibility in consanguineous populations 6. The transporter represents a critical component of renal organic anion elimination pathways.

Sources cited
1
SLC17A3 is a voltage-driven, multispecific organic anion transporter on renal apical membranes that transports urate and various drugs
PMID: 20810651
2
SLC17A3 mediates renal excretion of N-lactoyl-phenylalanine (Lac-Phe) in both mice and humans
PMID: 39134528
3
SLC17A3 transports uremic toxin 3-indoxyl sulfate with specific kinetic parameters (Km = 4.52 mM)
PMID: 38641061
4
Loss-of-function mutations in SLC17A3 cause urate underexcretion leading to hyperuricemia and gout
PMID: 27103454
5
SLC17A3 rs9379800 polymorphism is associated with increased ischemic stroke susceptibility in Malaysian populations
PMID: 34384670
6
SLC17A3 variants are implicated in type 1 diabetes susceptibility in Kuwaiti families
PMID: 37696853
Disease Associationsⓘ20
type 1 diabetes mellitusOpen Targets
0.06Suggestive
goutOpen Targets
0.06Suggestive
hypoxanthine guanine phosphoribosyltransferase partial deficiencyOpen Targets
0.05Suggestive
familial juvenile hyperuricemic nephropathy type 1Open Targets
0.05Suggestive
xanthinuria type IIOpen Targets
0.05Suggestive
Hyperuricemia - anemia - renal failureOpen Targets
0.04Suggestive
inflammatory bowel diseaseOpen Targets
0.04Suggestive
cystinuriaOpen Targets
0.04Suggestive
hereditary renal hypouricemiaOpen Targets
0.04Suggestive
colorectal cancerOpen Targets
0.04Suggestive
adenine phosphoribosyltransferase deficiencyOpen Targets
0.04Suggestive
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosisOpen Targets
0.03Suggestive
karyomegalic interstitial nephritisOpen Targets
0.03Suggestive
autosomal dominant progressive nephropathy with hypertensionOpen Targets
0.03Suggestive
familial juvenile hyperuricemic nephropathy type 2Open Targets
0.03Suggestive
hyperuricemic nephropathy, familial juvenile type 3Open Targets
0.03Suggestive
xanthinuria type IOpen Targets
0.03Suggestive
Fanconi renotubular syndrome 1Open Targets
0.03Suggestive
primary Fanconi syndromeOpen Targets
0.03Suggestive
primary hyperoxaluria type 3Open Targets
0.03Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SLC22A6Protein interaction82%SLC22A8Protein interaction82%SLC22A13Protein interaction82%SLC2A9Protein interaction82%SLC37A4Protein interaction80%SLC22A11Protein interaction76%
Tissue Expression6 tissues
Liver
100%
Ovary
1%
Lung
0%
Brain
0%
Bone Marrow
0%
Heart
0%
Gene Interaction Network
Click a node to explore
SLC17A3SLC22A6SLC22A8SLC22A13SLC2A9SLC37A4SLC22A11
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt O00476
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.18LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.94 [0.75–1.18]
RankingsWhere SLC17A3 stands among ~20K protein-coding genes
  • #12,875of 20,598
    Most Researched26
  • #12,390of 17,882
    Most Constrained (LOEUF)1.18
Genes detectedSLC17A3
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
SLC17A1/3 transporters mediate renal excretion of Lac-Phe in mice and humans.
PMID: 39134528
Nat Commun · 2024
1.00
2
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
PMID: 20810651
J Biol Chem · 2010
0.90
3
Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals.
PMID: 37235137
JHEP Rep · 2023
0.80
4
Role of Organic Anion Transporter NPT4 in Renal Handling of Uremic Toxin 3-indoxyl Sulfate.
PMID: 38641061
J Pharm Sci · 2024
0.70
5
Research progress in the genetics of hyperuricaemia and gout.
PMID: 27103454
Yi Chuan · 2016
0.60